| scholarly article | Q13442814 |
| P2093 | author name string | Pria Anand | |
| Farrah J Mateen | |||
| Nagagopal Venna | |||
| Andre Vogel | |||
| Gladia C Hotan | |||
| P2860 | cites work | Progressive multifocal leukoencephalopathy | Q85636689 |
| Progressive multifocal leukoencephalopathy treated with nivolumab | Q92318946 | ||
| Natalizumab-associated progressive multifocal leukoencephalopathy in Germany | Q92885493 | ||
| Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab | Q92999393 | ||
| Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy | Q92999413 | ||
| Progressive multifocal leukoencephalopathy in a patient treated with natalizumab | Q28255536 | ||
| Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis | Q28255548 | ||
| PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
| Progressive multifocal leukoencephalopathy in patients with HIV infection | Q32073645 | ||
| Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. | Q33502327 | ||
| Risk of natalizumab-associated progressive multifocal leukoencephalopathy | Q34275329 | ||
| Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease | Q34538727 | ||
| Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy | Q34802752 | ||
| Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis | Q36190565 | ||
| Diagnostic delay in progressive multifocal leukoencephalopathy | Q36891735 | ||
| Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies | Q37331090 | ||
| Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study | Q37434587 | ||
| Opportunistic infections and other risks with newer multiple sclerosis therapies | Q37462610 | ||
| Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS). | Q37779049 | ||
| No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML. | Q38754429 | ||
| JC Virus-Related Progressive Multifocal Leukoencephalopathy After Living-Donor Liver Transplant: A Rare Case | Q40085880 | ||
| Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy | Q43795314 | ||
| Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies | Q44417521 | ||
| Progressive multifocal leukoencephalopathy in HIV-1-infected children | Q48449974 | ||
| Progressive multifocal leukoencephalopathy: clinical and radiographic features | Q48497991 | ||
| Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon | Q48499031 | ||
| Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study | Q48828618 | ||
| The national incidence of PML in Sweden, 1988-2013. | Q50102128 | ||
| Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4). | Q52596046 | ||
| Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report. | Q54229030 | ||
| Performance of PML diagnostic criteria in natalizumab-associated PML: data from the Dutch-Belgian cohort | Q56888669 | ||
| Progressive multifocal leucoencephalopathy in a patient with sarcoidosis--successful treatment with cidofovir and mirtazapine | Q80050569 | ||
| P433 | issue | 6 | |
| P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
| P577 | publication date | 2019-09-25 | |
| P1433 | published in | Neurology(R) neuroimmunology & neuroinflammation | Q27725776 |
| P1476 | title | Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study | |
| P478 | volume | 6 |
| Q91635987 | Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy |
| Q97418947 | JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review |
| Q89520859 | PD-1 inhibition: a novel approach to the treatment of progressive multifocal leukoencephalopathy |
| Q90288758 | Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration |
Search more.